Altrius Capital Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.72M Sell
27,493
-1,944
-7% -$453K 1.34% 33
2025
Q4
$6.09M Sell
29,437
-606
-2% -$120K 1.29% 29
2025
Q3
$5.57M Buy
30,043
+134
+0.4% +$23K 1.27% 32
2025
Q2
$4.57M Buy
29,909
+75
+0.3% +$11.5K 1.07% 49
2025
Q1
$4.95M Buy
29,834
+574
+2% +$89.8K 1.2% 41
2024
Q4
$4.23M Buy
29,260
+626
+2% +$97K 1.14% 52
2024
Q3
$4.64M Buy
28,634
+412
+1% +$65.6K 1.16% 51
2024
Q2
$4.12M Buy
28,222
+3,210
+13% +$477K 1.09% 56
2024
Q1
$3.96M Buy
25,012
+2,415
+11% +$384K 1% 62
2023
Q4
$3.54M Buy
22,597
+147
+0.7% +$22.5K 0.99% 61
2023
Q3
$3.5M Buy
22,450
+260
+1% +$42.9K 1.04% 47
2023
Q2
$3.67M Buy
22,190
+171
+0.8% +$27.6K 1.09% 34
2023
Q1
$3.41M Buy
22,019
+3,793
+21% +$612K 1.04% 45
2022
Q4
$3.22M Sell
18,226
-81
-0.4% -$14K 1.01% 55
2022
Q3
$2.99M Sell
18,307
-7,444
-29% -$1.26M 1.14% 37
2022
Q2
$4.57M Buy
+25,751
New +$4.59M 1.49% 19

Other funds holding JNJ

Altrius Capital Management's JNJ Position: Q1 2026 in Review

Altrius Capital Management reduced its Johnson & Johnson (JNJ) stake by 6.6% in Q1 2026, selling an estimated $453K and leaving 27,493 shares worth $6.72M. The position accounts for 1.34% of the portfolio, ranked #33.

Altrius Capital Management first reported a position in JNJ in Q2 2022 and has held it in 16 quarters since. 4,615 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Altrius Capital Management held 27,493 shares of Johnson & Johnson worth $6.72M as of Q1 2026.
  • Altrius Capital Management sold 1,944 Johnson & Johnson shares in Q1 2026, an estimated $453K.
  • Johnson & Johnson made up 1.34% of Altrius Capital Management's portfolio in Q1 2026, its #33 holding.
  • Altrius Capital Management first reported a position in Johnson & Johnson in Q2 2022 and has held it in 16 quarters since.
  • 4,615 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Altrius Capital Management's 13F filing for Q1 2026, filed 5 May 2026.